WHO adds GLP-1RAs to essential medicines list Â
The World Health Organisation (WHO) has added key obesity and type 2 diabetes (T2D) medications semaglutide, tirzepatide, liraglutide…
Genetic suppression features ABHD18 as a Barth syndrome therapeutic target
Schlame, M. & Xu, Y. The function of tafazzin, a mitochondrial phospholipid-lysophospholipid acyltransferase. J. Mol. Biol. 432, 5043–5051…